Stuart Barnscher BSc

Stuart Barnscher is a Senior Scientist and the ADC Biology Group Leader at Zymeworks, focusing on the design and functional characterization of ADCs. Prior to joining Zymeworks in 2016 and while at Kairos Therapeutics, Stuart was a key contributor to the development of the ZymeLink platform which is comprised of a suite of toxins and drug-linkers. Prior to working at Kairos, Stuart was a synthetic organic chemist at Agensys in the ADC Chemistry group where he designed and synthesized toxins and drug-linkers across multiple payload classes.